AU8083094A - A diagnostic assay for alzheimer's disease: assessment of abeta abnormalities - Google Patents
A diagnostic assay for alzheimer's disease: assessment of abeta abnormalitiesInfo
- Publication number
- AU8083094A AU8083094A AU80830/94A AU8083094A AU8083094A AU 8083094 A AU8083094 A AU 8083094A AU 80830/94 A AU80830/94 A AU 80830/94A AU 8083094 A AU8083094 A AU 8083094A AU 8083094 A AU8083094 A AU 8083094A
- Authority
- AU
- Australia
- Prior art keywords
- abeta
- abnormalities
- alzheimer
- assessment
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1994/011895 WO1996012544A1 (en) | 1994-10-19 | 1994-10-19 | A DIAGNOSTIC ASSAY FOR ALZHEIMER'S DISEASE: ASSESSMENT OF Aβ ABNORMALITIES |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8083094A true AU8083094A (en) | 1996-05-15 |
Family
ID=22243151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU80830/94A Abandoned AU8083094A (en) | 1994-10-19 | 1994-10-19 | A diagnostic assay for alzheimer's disease: assessment of abeta abnormalities |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU8083094A (en) |
CA (1) | CA2203142C (en) |
WO (1) | WO1996012544A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7045531B1 (en) | 1997-03-11 | 2006-05-16 | The General Hospital Corporation | Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator |
US7078191B1 (en) | 1997-08-01 | 2006-07-18 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
EP1005654B1 (en) | 1997-08-01 | 2006-04-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel method of detecting amyloid-like fibrils or protein aggregates |
ATE323288T1 (en) * | 1997-08-01 | 2006-04-15 | METHOD FOR DETERMINING AMYLOID-LIKE FIBRILES OR PROTEIN AGGREGATES | |
US6638711B1 (en) | 1999-04-29 | 2003-10-28 | The General Hospital Corporation | Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation |
PT2579042E (en) | 2011-10-04 | 2014-09-09 | Affiris Ag | Method for detecting aãy-specific antibodies in a biological sample |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4666829A (en) * | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
US5231000A (en) * | 1987-10-08 | 1993-07-27 | The Mclean Hospital | Antibodies to A4 amyloid peptide |
US5262332A (en) * | 1989-04-05 | 1993-11-16 | Brigham And Women's Hospital | Diagnostic method for Alzheimer's disease: examination of non-neural tissue |
EP0683234B2 (en) * | 1993-01-25 | 2007-06-06 | Takeda Chemical Industries, Ltd. | Antibody against beta-amyloid or their derivative and use thereof |
-
1994
- 1994-10-19 AU AU80830/94A patent/AU8083094A/en not_active Abandoned
- 1994-10-19 CA CA002203142A patent/CA2203142C/en not_active Expired - Fee Related
- 1994-10-19 WO PCT/US1994/011895 patent/WO1996012544A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1996012544A1 (en) | 1996-05-02 |
CA2203142C (en) | 2006-01-31 |
CA2203142A1 (en) | 1996-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3891499A (en) | Diagnostic tests for alzheimer's disease | |
AU5508798A (en) | Diagnostic and therapeutic reagents for alzheimer's disease | |
AU2610901A (en) | Predictive diagnostic for alzheimer's disease | |
EP0773797A4 (en) | A method of diagnosing alzheimer's disease | |
AU2414092A (en) | Diagnostic method for alzheimer's disease | |
AU1407399A (en) | Treatment for alzheimer's disease | |
EP1011415A4 (en) | Non-invasive method for diagnosing alzheimer's disease in a patient | |
AU672379B2 (en) | Diagnostic assay for Alzheimer's Disease based on the proteolysis of Alzheimer's precursor protein | |
AU1837495A (en) | Computer assisted methods for diagnosing diseases | |
AU5292290A (en) | Diagnostic method for alzheimer's disease: examination of non-neural tissue | |
AU7708498A (en) | Nematode model for alzheimer's disease | |
AU7556994A (en) | Methods for the diagnosis of alzheimer's disease | |
AU8388098A (en) | Assays for diagnosis of thrombophilic disease | |
AU1441988A (en) | Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor | |
AU5857296A (en) | Use of leukotriene antagonists for alzheimer's disease | |
HUP0003684A3 (en) | Diagnostic test for alzheimer's disease | |
AU2001236592A1 (en) | Methods for diagnosis of alzheimer's disease | |
AUPN649395A0 (en) | A method for diagnosing alzheimer's disease | |
AU4636993A (en) | Diagnosing alzheimer's disease and schizophrenia | |
IL118925A0 (en) | Substituted cinnamic acid guanidides a process for their preparation their use as medicaments or diagnostic agents and medicaments comprising them | |
AU3068899A (en) | Diagnostic assay for late-onset alzheimer's disease | |
AU8083094A (en) | A diagnostic assay for alzheimer's disease: assessment of abeta abnormalities | |
AU5053296A (en) | Pharmaceutical agents for the treatment of Alzheimer's disease | |
IL140222A0 (en) | A method and diagnostic kit for detecting alzheimer's disease | |
AU1405899A (en) | Treatment for alzheimer's disease |